Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RBR-8wt2fyPhase 4Completed
Phase 4, randomised, open-label trial of propofol and sevoflurane in class III obesity (2 arms), sponsored by Adriano Teixeira Fernandes. Primary endpoints: Incidence of acute kidney injury, Serum creatinine and 2 more. Started Oct 2010; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on RBR-8wt2fy.